Viral/microbial/biological carcinogenesis HPV HBV EBV md pathology exam Robbins based answer which I can replicate

Reading File

Finding Sources

Searching PubMed

oncogenic viruses AND cancer

Searching the Web

WHO biological carcinogens HPV HBV EBV cancer fact sheet

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Viral, Microbial and Biological Carcinogenesis

Robbins-based MD Pathology Answer

Introduction

Biological agents cause cancer by either:

Direct transformation of cells through viral oncogenes or viral proteins that inhibit tumor suppressor genes, or
Indirect mechanisms such as chronic inflammation, repeated cell injury and regeneration, immunosuppression, and increased cell proliferation.

A common feature is:
infection → polyclonal cellular proliferation → accumulation of mutations → monoclonal malignant tumor.

Important infectious agents associated with cancer include:

Human papillomavirus (HPV)
Epstein-Barr virus (EBV)
Hepatitis B virus (HBV) and hepatitis C virus (HCV)
Human T-cell leukemia virus-1 (HTLV-1)
Human herpesvirus-8 (HHV-8/KSHV)
Merkel cell polyomavirus
Helicobacter pylori
Some parasites, especially Schistosoma haematobium and liver flukes

Robbins notes that HPV, EBV, and hepatitis viruses account collectively for a substantial proportion of cancers globally. Robbins & Kumar Basic Pathology, pp. 252-255.

1. Human Papillomavirus (HPV)

Associated tumors

High-risk HPV, especially HPV 16 and 18, is associated with:

Squamous cell carcinoma of cervix
Anogenital carcinomas: vulva, vagina, penis, anus
Oropharyngeal squamous cell carcinoma, especially tonsil and base of tongue

Low-risk types HPV 6 and 11 usually cause genital warts and have minimal malignant potential.

Pathogenesis

In precursor lesions, HPV DNA is usually present as an episome. In carcinoma, viral DNA often becomes integrated into the host genome.

Integration disrupts the viral E2 regulatory gene, causing overexpression of the viral oncoproteins E6 and E7.

E6 protein

Binds p53 and promotes its degradation
Prevents p53-mediated cell-cycle arrest and apoptosis
Upregulates TERT/telomerase
Causes cellular immortalization

E7 protein

Binds and inactivates RB protein
Releases E2F transcription factors
Drives G1 to S phase progression
Also inhibits CDK inhibitors such as p21 and p27

Result

Loss of p53 and RB checkpoint function causes:

Increased cellular proliferation
Reduced apoptosis
Genomic instability
Immortalization

Flowchart for exam:

High-risk HPV infection → viral DNA integration → loss of E2 repression → ↑ E6 and E7 →
E6 degrades p53 + activates telomerase; E7 inhibits RB and p21 →
unchecked G1-S transition + impaired apoptosis + immortalization → carcinoma.

Important point: HPV infection alone is not sufficient. Additional mutations in host-cell genes are necessary for malignant transformation.

Robbins & Kumar Basic Pathology, pp. 253-254.

2. Epstein-Barr Virus (EBV)

Associated tumors

EBV is associated with:

Endemic Burkitt lymphoma
Some cases of Hodgkin lymphoma
Post-transplant lymphoproliferative disorder and B-cell lymphoma in immunosuppressed persons
Nasopharyngeal carcinoma
Some gastric carcinomas
Some NK/T-cell lymphomas
Rare smooth-muscle tumors in immunosuppressed patients

Pathogenesis

EBV infects B cells through CD21, the complement receptor.

It causes polyclonal B-cell proliferation and immortalization through latent viral proteins:

Latent membrane protein-1 (LMP-1)

Functions like a constitutively active CD40 receptor
Activates NF-kB and JAK/STAT pathways
Promotes B-cell survival and proliferation
Has anti-apoptotic effects

EBNA-2

Increases expression of:
- Cyclin D
- SRC-family proto-oncogenes
- Other growth-promoting cellular genes

In immunocompetent people, cytotoxic T lymphocytes control EBV-infected B cells. In immunosuppressed individuals, this immune control fails, permitting expansion of EBV-infected B cells and lymphoma development.

EBV and Burkitt lymphoma

In endemic Burkitt lymphoma, chronic malaria-associated immune impairment may permit prolonged EBV-driven B-cell proliferation. Acquisition of MYC translocation, most often t(8;14), produces overt lymphoma.

Flowchart:

EBV infects B cell via CD21 → LMP-1 and EBNA-2 stimulate B-cell proliferation → polyclonal proliferation → immune failure/additional mutations, especially MYC translocation → monoclonal B-cell lymphoma.

Robbins & Kumar Basic Pathology, pp. 254-255.

3. Hepatitis B Virus (HBV)

Associated tumor

Hepatocellular carcinoma (HCC)

Chronic HBV infection is a major cause of HCC. HCV also causes HCC, mainly by chronic inflammation and regeneration.

Mechanisms of HBV carcinogenesis

A. Chronic inflammation and regeneration

Persistent HBV infection causes:

Chronic hepatitis → hepatocyte death → compensatory regeneration → cirrhosis → dysplasia → hepatocellular carcinoma.

Repeated cell division increases the likelihood of mutations in cancer-related genes.

B. Integration of HBV DNA into host genome

HBV DNA can integrate randomly into hepatocyte DNA, producing genomic instability and sometimes altering expression of cellular genes.

C. HBx protein

HBx protein has multiple effects:

Promotes transcription of cellular growth-regulatory genes
Activates signaling pathways that favor cell growth
May interfere with p53 function
Contributes to genomic instability and impaired DNA repair

Important point

Unlike HPV, HBV carcinogenesis is mainly due to chronic necroinflammatory liver injury and regeneration, with a contributory direct role of viral DNA integration and HBx protein.

Flowchart:

Chronic HBV infection → chronic hepatitis → necrosis + regeneration → cirrhosis → accumulation of mutations → HCC.
HBV DNA integration + HBx activity accelerate genomic instability and transformation.

Chronic HBV and HCV infection are associated with most hepatocellular carcinomas in regions where these infections are prevalent. Robbins & Kumar Basic Pathology, Liver chapter, Hepatitis B Virus section.

4. Human T-Cell Leukemia Virus-1 (HTLV-1)

Associated tumor

Adult T-cell leukemia/lymphoma (ATLL)

HTLV-1 infects CD4+ T cells. It is endemic in Japan, the Caribbean, parts of Africa, and South America.

Pathogenesis

HTLV-1 does not carry a classical viral oncogene. Its transforming effect is due mainly to viral regulatory proteins:

Tax
HBZ

Tax activates host-cell growth and survival pathways, including:

NF-kB
PI3K signaling
Transcription of growth-promoting genes

This produces polyclonal T-cell proliferation and genomic instability. After a long latency, additional mutations lead to a monoclonal malignant T-cell population.

Key points

Latency: often 40-60 years
Only a small proportion of infected persons develop ATLL
Clonal viral integration in tumor cells proves infection occurred before transformation

Robbins & Kumar Basic Pathology, p. 252.

5. Human Herpesvirus-8 (HHV-8/KSHV)

Associated tumors

Kaposi sarcoma
Primary effusion lymphoma
Some multicentric Castleman disease

Mechanism

HHV-8 encodes proteins that mimic human growth-regulatory proteins, including:

Viral cyclin
Viral BCL-2
Viral IL-6
G-protein-coupled receptor homologues

These viral products promote cell survival, angiogenesis, and proliferation. Tumors occur especially in immunosuppressed persons, such as those with HIV/AIDS or transplant recipients.

6. Merkel Cell Polyomavirus

Associated tumor

Merkel cell carcinoma, an aggressive neuroendocrine carcinoma of skin

Mechanism

In tumor cells, viral DNA integrates clonally into the host genome. Viral T antigens inactivate important tumor suppressor pathways, including RB, leading to uncontrolled proliferation.

7. Hepatitis C Virus (HCV)

Associated tumor

Hepatocellular carcinoma

HCV is an RNA virus and does not integrate into host DNA. Its carcinogenic effect is primarily indirect:

Persistent HCV infection → chronic hepatitis → hepatocyte death and regeneration → fibrosis/cirrhosis → HCC.

Microbial Carcinogenesis

8. Helicobacter pylori

Associated tumors

Gastric adenocarcinoma, especially intestinal type
Gastric MALT lymphoma

Pathogenesis of gastric adenocarcinoma

Persistent H. pylori infection causes chronic gastritis. With time, this may progress through the following sequence:

Chronic gastritis → multifocal atrophic gastritis → intestinal metaplasia → dysplasia → gastric adenocarcinoma.

Virulence factors include:

Urease: protects organism in acidic stomach
Flagella: permit movement through mucus
Adhesins: allow attachment to foveolar epithelial cells
CagA and CagE toxins: stimulate cytokines, especially IL-8, causing persistent inflammation and mucosal damage

Chronic inflammation, epithelial injury, oxidative stress, and regeneration cause progressive accumulation of genetic abnormalities.

Pathogenesis of MALT lymphoma

Chronic antigenic stimulation by H. pylori causes polyclonal B-cell proliferation in gastric mucosa. This can evolve into monoclonal MALT lymphoma. Early lesions may regress after eradication of H. pylori.

Robbins & Kumar Basic Pathology, gastric pathology section.

9. Parasites Associated with Cancer

Schistosoma haematobium

Associated with squamous cell carcinoma of urinary bladder
Mechanism: chronic cystitis, irritation, inflammation, and epithelial regeneration

Opisthorchis viverrini and Clonorchis sinensis

Associated with cholangiocarcinoma
Mechanism: chronic inflammation and injury to biliary epithelium

Summary Table for Revision

Agent	Main tumor(s)	Important mechanism
HPV 16, 18	Cervical, anogenital, oropharyngeal SCC	E6 inhibits p53 and activates telomerase; E7 inhibits RB
EBV	Burkitt lymphoma, nasopharyngeal carcinoma, some Hodgkin lymphomas, PTLD	LMP-1 activates NF-kB/JAK-STAT; EBNA-2 promotes growth; immune failure and MYC mutation
HBV	HCC	Chronic hepatitis/cirrhosis, DNA integration, HBx protein
HCV	HCC	Chronic inflammation, regeneration, cirrhosis
HTLV-1	Adult T-cell leukemia/lymphoma	Tax/HBZ activate growth and survival pathways
HHV-8	Kaposi sarcoma, primary effusion lymphoma	Viral homologues of cyclin, BCL-2, IL-6; angiogenesis
Merkel cell polyomavirus	Merkel cell carcinoma	T antigens disrupt RB pathway
H. pylori	Gastric adenocarcinoma, MALT lymphoma	Chronic gastritis, atrophy, metaplasia; antigen-driven B-cell proliferation
S. haematobium	Bladder SCC	Chronic inflammation and irritation
Liver flukes	Cholangiocarcinoma	Chronic cholangitis and biliary epithelial injury

Last-minute mnemonic

“HPV-E6 p53, E7 RB”

E6 eats p53
E7 eliminates RB

“EBV makes B cells Busy”
LMP-1 and EBNA-2 drive B-cell growth.

“HBV hurts liver repeatedly”
Chronic hepatitis and regeneration lead to HCC.

“H. pylori: gastritis to gastric cancer”
Chronic gastritis → atrophy → intestinal metaplasia → dysplasia → carcinoma.

A recent systematic review of oncogenic viruses in head-and-neck carcinogenesis supports the continuing importance of viral cancer associations, especially HPV-related disease, though it does not alter the core Robbins mechanisms described above (2025 review, PMID 39551637).

This is a shared conversation. Sign in to Orris to start your own chat.